Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
This grant supports NCI-designated Cancer Centers in advancing cancer research, collaboration, and resource sharing across basic, clinical, and population-based science.
Funder: National Institutes of Health
Due Dates: September 25, 2028 (final deadline for this cycle)
Funding Amounts: Award amounts vary by center type and are based on the scope of the application; multi-year support available; no explicit max listed.
Summary: Supports NCI-Designated Cancer Centers in advancing cancer research, shared resources, and community dissemination.
Key Information: Applicants must meet substantial NIH/peer-reviewed cancer funding base requirements; foreign organizations are not eligible.
Description
This program provides Cancer Center Support Grants (CCSGs) to NCI-Designated Cancer Centers, supporting three types of centers: Comprehensive, Clinical, and Basic. The grants are intended to foster institutional cancer research capabilities, integrate meritorious research across disciplines, and serve as major sources of discovery in cancer prevention, diagnosis, and therapy. Funded centers are expected to develop shared resources, coordinate with other NCI-funded programs, and disseminate research findings to benefit the broader community.
